227 related articles for article (PubMed ID: 31211918)
1. Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.
Huang J; Lu W; Ouyang H; Chen Y; Zhang C; Luo X; Li M; Shu J; Zheng Q; Chen H; Chen J; Tang H; Sun D; Yuan JX; Yang K; Wang J
Am J Respir Cell Mol Biol; 2020 Jan; 62(1):49-60. PubMed ID: 31211918
[TBL] [Abstract][Full Text] [Related]
2. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
[TBL] [Abstract][Full Text] [Related]
3. Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway.
Wang EL; Zhang JJ; Luo FM; Fu MY; Li D; Peng J; Liu B
Life Sci; 2023 Sep; 328():121879. PubMed ID: 37355224
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension.
Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
Eur J Pharmacol; 2019 Nov; 863():172673. PubMed ID: 31542480
[TBL] [Abstract][Full Text] [Related]
5. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia induces endothelial‑mesenchymal transition in pulmonary vascular remodeling.
Zhang B; Niu W; Dong HY; Liu ML; Luo Y; Li ZC
Int J Mol Med; 2018 Jul; 42(1):270-278. PubMed ID: 29568878
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
Jiang DT; Tuo L; Bai X; Bing WD; Qu QX; Zhao X; Song GM; Bi YW; Sun WY
Stem Cell Res Ther; 2022 Jul; 13(1):316. PubMed ID: 35842683
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.
Yu M; Peng L; Liu P; Yang M; Zhou H; Ding Y; Wang J; Huang W; Tan Q; Wang Y; Xie W; Kong H; Wang H
Drug Des Devel Ther; 2020; 14():1191-1202. PubMed ID: 32256050
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.
Klinger JR; Pereira M; Del Tatto M; Brodsky AS; Wu KQ; Dooner MS; Borgovan T; Wen S; Goldberg LR; Aliotta JM; Ventetuolo CE; Quesenberry PJ; Liang OD
Am J Respir Cell Mol Biol; 2020 May; 62(5):577-587. PubMed ID: 31721618
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats.
Takemiya K; Kai H; Yasukawa H; Tahara N; Kato S; Imaizumi T
Basic Res Cardiol; 2010 May; 105(3):409-17. PubMed ID: 19838762
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells alleviate palmitic acid-induced endothelial-to-mesenchymal transition by suppressing endoplasmic reticulum stress.
Luo R; Li L; Liu X; Yuan Y; Zhu W; Li L; Liu J; Lu Y; Cheng J; Chen Y
Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E961-E980. PubMed ID: 33044844
[TBL] [Abstract][Full Text] [Related]
13. Loss of lung microvascular endothelial Piezo2 expression impairs NO synthesis, induces EndMT, and is associated with pulmonary hypertension.
Tian S; Cai Z; Sen P; van Uden D; van de Kamp E; Thuillet R; Tu L; Guignabert C; Boomars K; Van der Heiden K; Brandt MM; Merkus D
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H958-H974. PubMed ID: 36149769
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
Kang K; Xiang J; Zhang X; Xie Y; Zhou M; Zeng L; Zhuang J; Kuang J; Lin Y; Hu B; Xiong Q; Yin Q; Su Q; Liao X; Wang J; Niu Y; Liu C; Tian J; Gou D
Cell Mol Biol Lett; 2024 May; 29(1):69. PubMed ID: 38741032
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation.
Tsutsumi T; Nagaoka T; Yoshida T; Wang L; Kuriyama S; Suzuki Y; Nagata Y; Harada N; Kodama Y; Takahashi F; Morio Y; Takahashi K
PLoS One; 2019; 14(7):e0214697. PubMed ID: 31339889
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling.
Zhang S; Liu X; Ge LL; Li K; Sun Y; Wang F; Han Y; Sun C; Wang J; Jiang W; Xin Q; Xu C; Chen Y; Chen O; Zhang Z; Luan Y
Respir Res; 2020 Mar; 21(1):71. PubMed ID: 32192495
[TBL] [Abstract][Full Text] [Related]
18. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.
Baber SR; Deng W; Master RG; Bunnell BA; Taylor BK; Murthy SN; Hyman AL; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1120-8. PubMed ID: 16980338
[TBL] [Abstract][Full Text] [Related]
19. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
20. Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.
Gorelova A; Berman M; Al Ghouleh I
Antioxid Redox Signal; 2021 Apr; 34(12):891-914. PubMed ID: 32746619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
